Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Squamous Intraepithelial Lesions 2Warts 1Sarcoma, Kaposi 1Sarcoma 1Precancerous Conditions 1Anus Neoplasms 1AIDS-related Kaposi sarcoma 1

Interventions

resiquimod 6lactic acid, salicylic acid drug combination 1human papillomavirus vaccine, L1 type 16, 18 1VP-102 1Sugars 1PRA1 protein, Candida albicans 1Nitric Oxide 1Maltose 1Interferon-alpha 1Cidofovir 1Cholecalciferol 1Cantharidin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Warts × Cidofovir × Clear all
NCT02567149 2017-07-02

Intralesional Cidofovir for the Treatment of Recalcitrant Warts in the Pediatric Immune-suppressed Population.

University of Minnesota

Phase 2 Withdrawn

Warts

Data powered by HemOnc (CC BY 4.0) Colophon âš¡